BRUKER CORPORATION Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, Tax
BRUKER CORPORATION (BRKR) reported Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, Tax of -$1.40 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-27.
Financial Statements › Expense Statement › Income Tax
us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax · last filed 2026-02-27
- BRUKER CORPORATION other comprehensive (income) loss, defined benefit plan, after reclassification adjustment, tax for the quarter ending 2025-12-31 was -$2.50M, a 151.02% decline year-over-year.
- BRUKER CORPORATION other comprehensive (income) loss, defined benefit plan, after reclassification adjustment, tax for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- BRUKER CORPORATION other comprehensive (income) loss, defined benefit plan, after reclassification adjustment, tax for the quarter ending 2025-06-30 was $900.00K.
- BRUKER CORPORATION other comprehensive (income) loss, defined benefit plan, after reclassification adjustment, tax for the quarter ending 2025-03-31 was $200.00K.
- BRUKER CORPORATION other comprehensive (income) loss, defined benefit plan, after reclassification adjustment, tax for fiscal 2025 was -$1.40M, a 128.00% decline from fiscal 2024.
- BRUKER CORPORATION other comprehensive (income) loss, defined benefit plan, after reclassification adjustment, tax for fiscal 2024 was $5.00M, a 1.96% decline from fiscal 2023.
- BRUKER CORPORATION other comprehensive (income) loss, defined benefit plan, after reclassification adjustment, tax for fiscal 2023 was $5.10M.
- BRUKER CORPORATION other comprehensive (income) loss, defined benefit plan, after reclassification adjustment, tax for fiscal 2022 was -$11.80M, a 402.56% decline from fiscal 2021.
| Period end | Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, Tax 3 month | Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, Tax 3 month as first filed | Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, Tax 6 month | Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, Tax 9 month | Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, Tax 12 month | Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, Tax 12 month as first filed |
|---|---|---|---|---|---|---|
| 2025-12-31 | -$2.50M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | -$2.50M derived: sum of 2 quarters · filed 2026-02-27 | -$1.60M derived: sum of 3 quarters · filed 2026-02-27 | -$1.40M 10-K · filed 2026-02-27 | ||
| 2025-09-30 | $0.00 10-Q · filed 2025-11-05 | $900.00K derived: sum of 2 quarters · filed 2025-11-05 | $1.10M 10-Q · filed 2025-11-05 | $6.00M derived: sum of 4 quarters · filed 2026-02-27 | ||
| 2025-06-30 | $900.00K 10-Q · filed 2025-08-06 | $1.10M 10-Q · filed 2025-08-06 | $6.00M derived: sum of 3 quarters · filed 2026-02-27 | $6.20M derived: sum of 4 quarters · filed 2026-02-27 | ||
| 2025-03-31 | $200.00K 10-Q · filed 2025-05-07 | $5.10M derived: sum of 2 quarters · filed 2026-02-27 | $5.30M derived: sum of 3 quarters · filed 2026-02-27 | $5.30M derived: sum of 4 quarters · filed 2026-02-27 | ||
| 2024-12-31 | $4.90M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $5.10M derived: sum of 2 quarters · filed 2026-02-27 | $5.10M derived: sum of 3 quarters · filed 2026-02-27 | $5.00M 10-K · filed 2026-02-27 | ||
| 2024-09-30 | $200.00K 10-Q · filed 2025-11-05 | $100.00K 10-Q · filed 2024-11-07 | $200.00K derived: sum of 2 quarters · filed 2025-11-05 | $100.00K 10-Q · filed 2025-11-05 | $5.80M derived: sum of 4 quarters · filed 2026-02-27 | |
| 2024-06-30 | $0.00 10-Q · filed 2025-08-06 | $0.00 10-Q · filed 2025-08-06 | $5.60M derived: sum of 3 quarters · filed 2026-02-27 | $5.60M derived: sum of 4 quarters · filed 2026-02-27 | ||
| 2024-03-31 | -$100.00K 10-Q · filed 2025-05-07 | $100.00K 10-Q · filed 2024-05-10 | $5.60M derived: sum of 2 quarters · filed 2026-02-27 | $5.60M derived: sum of 3 quarters · filed 2026-02-27 | $5.80M derived: sum of 4 quarters · filed 2026-02-27 | |
| 2023-12-31 | $5.70M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $5.70M derived: sum of 2 quarters · filed 2026-02-27 | $5.90M derived: sum of 3 quarters · filed 2026-02-27 | $5.10M 10-K · filed 2026-02-27 | -$5.10M 10-K · filed 2024-02-29 | |
| 2023-09-30 | $0.00 10-Q · filed 2024-11-07 | $200.00K derived: sum of 2 quarters · filed 2024-11-07 | -$600.00K 10-Q · filed 2024-11-07 | |||
| 2023-06-30 | $200.00K 10-Q · filed 2024-08-09 | $600.00K 10-Q · filed 2024-08-09 | ||||
| 2023-03-31 | $500.00K 10-Q · filed 2024-05-10 | |||||
| 2022-12-31 | -$11.80M 10-K · filed 2025-03-03 | $11.80M 10-K · filed 2023-03-01 | ||||
| 2021-12-31 | $3.90M 10-K · filed 2024-02-29 | |||||
| 2020-12-31 | $1.70M 10-K · filed 2023-03-01 | |||||
| 2019-12-31 | $6.30M 10-K · filed 2022-02-28 | |||||
| 2018-12-31 | $3.80M 10-K · filed 2021-03-01 | |||||
| 2017-12-31 | $2.90M 10-K · filed 2020-03-27 | |||||
| 2016-12-31 | $2.10M 10-K · filed 2019-03-01 | |||||
| 2015-12-31 | $2.10M 10-K · filed 2018-03-16 | |||||
| 2014-12-31 | $6.50M 10-K · filed 2017-03-01 | |||||
| 2013-12-31 | $4.60M 10-K · filed 2016-02-29 | |||||
| 2012-12-31 | $3.70M 10-K · filed 2015-02-27 | |||||
| 2011-12-31 | $600.00K 10-K · filed 2014-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| REVVITY, INC. (RVTY) | United States | $16.814B | 53.44 |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |